Article info
PDFTuberculosis
Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries
- Correspondence to Dr A B Hardy, Leeds Teaching Hospitals NHS Trust, Department of Respiratory Machine, Beckett Street, Leeds LS9 7TF, UK; andrewbhardy{at}yahoo.co.uk
Citation
Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries
Publication history
- Received May 14, 2009
- Accepted November 11, 2009
- First published December 8, 2009.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited For permission to use, (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.